{
    "2020-10-30": [
        [
            {
                "time": "2020-10-29",
                "original_text": "药明康德发布2020年第三季度报告。2020Q3收入45.83亿元，较去年增长35.4%，经调整后净利润较去年同期增长44.3%。药明康德2020年第三季度营收增长的主要来源于中国区实验室和合同研发与生产业务 (CDMO)，较去年同期增长38.9%和54.9%。",
                "features": {
                    "keywords": [
                        "药明康德",
                        "三季报",
                        "收入增长",
                        "净利润增长",
                        "中国区实验室",
                        "CDMO"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "海外客户订单增长等原因，药明康德前三季度营收同比27.34%。",
                "features": {
                    "keywords": [
                        "药明康德",
                        "海外客户",
                        "订单增长",
                        "营收增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "惠誉：上调药明康德评级展望至正面，并确认其“BBB-”评级。",
                "features": {
                    "keywords": [
                        "惠誉",
                        "评级展望",
                        "上调",
                        "正面",
                        "BBB-"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "药明康德成功驳回集体诉讼。",
                "features": {
                    "keywords": [
                        "药明康德",
                        "集体诉讼",
                        "成功驳回"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "医疗健康-基金3Q分析：三季度医药板块配置比例同比上升 环比下降。",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "基金",
                        "医药板块",
                        "配置比例",
                        "同比上升",
                        "环比下降"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            }
        ]
    ]
}